Five things to know:
1. Reported revenue for full-year 2019 increased 3.1 percent to $1.52 billion, compared to 2018.
2. Global neurosurgery sales increased 7 percent year-over-year to $183.1 million.
3. Total orthopedics and tissue technology revenues rose 1.6 percent on an organic basis to $136 million, compared to the same period for the prior year.
4. For 2020, the company anticipates full-year adjusted earnings per diluted share to be in the range of $3 to $3.05.
5. Integra plans to grow its OTT line this year to “become a market leader in regenerative technologies,” Peter Arduini, president and CEO at Integra, said during the fourth quarter earnings call, transcribed by The Motley Fool.
More articles on devices:
Stryker ranks No. 8 in Fortune’s 100 best workplaces
Wuhan neurosurgeon, hospital director dies from coronavirus, death toll rises to 1,800+
Medtronic reports spine revenue up 3%, hurt by low BMP sales: 7 things to know
